Fig. 1From: Safety of an extended-release injectable moxidectin suspension formulation (ProHeart® 12) in dogsMoxidectin mean plasma concentrations in dogs administered 1×, 3×, and 5× the recommended 0.5 mg/kg dose at 6-month intervalsBack to article page